MedPath

Biogen Netherlands BV

🇳🇱Netherlands
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.biogen.nl

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

31

CIMA_AEMPS:16
EMA:10
NMPA:5

Drug Approvals

Nusinersen Sodium Injection

Product Name
诺西那生钠注射液
Approval Number
国药准字HJ20190032
Approval Date
Jan 15, 2024
NMPA

Fampridine Sustained-release Tablets

Product Name
氨吡啶缓释片
Approval Number
国药准字HJ20210031
Approval Date
May 11, 2021
NMPA

Dimethyl Fumarate Enteric Capsules

Product Name
富马酸二甲酯肠溶胶囊
Approval Number
国药准字HJ20210026
Approval Date
Apr 13, 2021
NMPA

Dimethyl Fumarate Enteric Capsules

Product Name
富马酸二甲酯肠溶胶囊
Approval Number
国药准字HJ20210025
Approval Date
Apr 13, 2021
NMPA

Nusinersen Sodium Injection

Product Name
诺西那生钠注射液
Approval Number
H20190032
Approval Date
Feb 22, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.